Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2007

View Archived Issues

Human papillomavirus vaccine 16/18 shows promise in phase III trial

Pharmacological activity of DZ-697b investigated in vitro

KDN-7438: a novel TF/FVIIa inhibitor with anticoagulant activity in vivo

Adenosine A2A agonism decreases acute inflammation and improves posthemorrhagic vasospasm in rats

Adenosine A2A antagonism has no effect on dopamine depletion-induced deficits in cognition

Epeius' targeted gene delivery system Rexin-G enters advanced phase I/II trials

Cell Genesys completes enrollment of phase III study of GVAX immunotherapy

Catalyst begins phase II trial of CPP-109 for cocaine dependence

Recent patents disclose new agents for respiratory and allergic disorders

Recent patents describe new treatment options for endocrine-related disorders

Novel therapeutic agents for obesity and lipoprotein disorders described in recent patents

J-30: a novel microtubule-disrupting agent with antitumor efficacy in vivo

Novel HDAC inhibitor described by CrystalGenomics

Fludara tablet launched in Japan

OT-551 holds promise for oncology and inflammatory conditions

Ziopharm reports positive interm data for phase II trial of ZIO-201

Critical Therapeutics begins enrollment for phase IV trial of Zyflo CR

Update on Progen's phase III trial design for liver cancer

Health Canada approves phase I trials of WBI-1001 for psoriasis

VivaGel trial begins in sexually active young women

Tercica and Genentech to codevelop Nutropin AQ and Increlex combination drug

Valeant selects pre-IND candidates for potassium-channel opener program

Inspire plans phase III trials of epinastine nasal spray for rhinitis

Peregrine advances study of bavituximab for HCV/HIV coinfection

Initial enrollment milestone reached in Vical's phase II CMV study

BioVant shows promise as adjuvant in H5N1 avian flu vaccine

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...